AR023789A1 - Composicion farmaceutica en forma unitaria que contiene acido acetilsalicilico y hidrogenosulfato de clopidogrel - Google Patents

Composicion farmaceutica en forma unitaria que contiene acido acetilsalicilico y hidrogenosulfato de clopidogrel

Info

Publication number
AR023789A1
AR023789A1 ARP000102020A ARP000102020A AR023789A1 AR 023789 A1 AR023789 A1 AR 023789A1 AR P000102020 A ARP000102020 A AR P000102020A AR P000102020 A ARP000102020 A AR P000102020A AR 023789 A1 AR023789 A1 AR 023789A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
acoptial
form containing
calcium acid
unitary form
Prior art date
Application number
ARP000102020A
Other languages
English (en)
Original Assignee
Addario Ezio Nicola D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Addario Ezio Nicola D filed Critical Addario Ezio Nicola D
Publication of AR023789A1 publication Critical patent/AR023789A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composicion farmacéutica que se presenta en forma galénica unitaria que contiene una asociacion de principios activos de actividad antiagreganteplaquetario constituida por ácido acetilsalicílico e hidrogenosulfato de clopidogrel.
ARP000102020A 1999-04-30 2000-04-28 Composicion farmaceutica en forma unitaria que contiene acido acetilsalicilico y hidrogenosulfato de clopidogrel AR023789A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9905497A FR2792836B3 (fr) 1999-04-30 1999-04-30 Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel

Publications (1)

Publication Number Publication Date
AR023789A1 true AR023789A1 (es) 2002-09-04

Family

ID=9545071

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102020A AR023789A1 (es) 1999-04-30 2000-04-28 Composicion farmaceutica en forma unitaria que contiene acido acetilsalicilico y hidrogenosulfato de clopidogrel

Country Status (24)

Country Link
EP (1) EP1178809A1 (es)
JP (1) JP2002543137A (es)
KR (1) KR20020005735A (es)
CN (1) CN1359294A (es)
AR (1) AR023789A1 (es)
AU (1) AU4303600A (es)
BR (1) BR0010194A (es)
CA (1) CA2371231A1 (es)
CZ (1) CZ20013887A3 (es)
EA (1) EA200100959A1 (es)
EE (1) EE200100559A (es)
FR (1) FR2792836B3 (es)
HK (1) HK1041823A1 (es)
HU (1) HUP0202329A2 (es)
IL (1) IL145648A0 (es)
IS (1) IS6084A (es)
MX (1) MXPA01011071A (es)
NO (1) NO20015295L (es)
NZ (1) NZ514248A (es)
PL (1) PL351923A1 (es)
SK (1) SK15542001A3 (es)
TR (1) TR200103039T2 (es)
UY (1) UY26131A1 (es)
WO (1) WO2000066130A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2262933C2 (ru) 2000-12-25 2005-10-27 Санкио Компани, Лимитед Медицинские композиции, содержащие аспирин
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
JP4917255B2 (ja) * 2003-10-16 2012-04-18 第一三共ヘルスケア株式会社 サリチル酸類含有経口組成物
WO2005070464A2 (en) * 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
CN101237868A (zh) * 2005-06-13 2008-08-06 伊兰制药国际有限公司 纳米粒氯吡格雷和阿司匹林组合制剂
KR20070009851A (ko) * 2005-07-14 2007-01-19 씨제이 주식회사 클로피도그렐 황산수소염 함유 약학 조성물
AU2006292946B2 (en) * 2005-09-21 2009-12-10 Chong Kun Dang Pharmaceutical Corp. Novel resinate complex of s-clopidogrel and production method thereof
KR20070044323A (ko) * 2005-10-24 2007-04-27 에스케이케미칼주식회사 보관안정성이 개선된 클로피도그렐 황산수소염 함유 경구용제제
JP2009532462A (ja) * 2006-04-05 2009-09-10 カディラ・ヘルスケア・リミテッド 調節放出クロピドグレル製剤
EP1900358A1 (en) * 2006-09-16 2008-03-19 Cimex Pharma AG Pharmaceutical formulations comprising clopidogrel
HUP0600839A3 (en) * 2006-11-14 2008-09-29 Egis Gyogyszergyar Nyrt Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof
KR100949273B1 (ko) * 2008-02-22 2010-03-25 한올제약주식회사 복합제제
CN101695496A (zh) * 2009-10-15 2010-04-21 苏春华 一种含有三氟柳和氯吡格雷的药物组合物
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤
RU2484820C2 (ru) * 2011-02-24 2013-06-20 Общество с ограниченной ответственностью "Озон" Комбинированное лекарственное средство, являющееся ингибитором агрегации тромбоцитов
KR101675501B1 (ko) 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
JP6004524B2 (ja) * 2012-07-11 2016-10-12 大原薬品工業株式会社 クロピドグレル硫酸塩含有錠剤の製造方法
JP5905165B2 (ja) * 2013-08-02 2016-04-20 サノフイ アセチルサリチル酸およびクロピドグレルを含む医薬錠剤
CN104434932B (zh) * 2014-12-18 2017-05-24 成都苑东生物制药股份有限公司 一种硫酸氢氯吡格雷阿司匹林片药物组合物及其制备方法
WO2017037741A1 (en) * 2015-09-02 2017-03-09 Sun Pharmaceutical Industries Ltd Compact solid dosage form of aspirin and clopidogrel
CN115737578A (zh) * 2022-11-23 2023-03-07 石家庄四药有限公司 一种硫酸氢氯吡格雷阿司匹林复方片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
US5576328A (en) * 1994-01-31 1996-11-19 Elf Sanofi Method for the secondary prevention of ischemic events
FR2744918B1 (fr) 1996-02-19 1998-05-07 Sanofi Sa Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel

Also Published As

Publication number Publication date
AU4303600A (en) 2000-11-17
HK1041823A1 (zh) 2002-07-26
JP2002543137A (ja) 2002-12-17
IL145648A0 (en) 2002-06-30
MXPA01011071A (es) 2002-07-22
EA200100959A1 (ru) 2002-06-27
PL351923A1 (en) 2003-06-30
NO20015295D0 (no) 2001-10-29
FR2792836A1 (fr) 2000-11-03
FR2792836B3 (fr) 2001-07-27
SK15542001A3 (sk) 2002-02-05
BR0010194A (pt) 2002-02-13
EE200100559A (et) 2003-02-17
NZ514248A (en) 2003-06-30
CZ20013887A3 (cs) 2002-02-13
EP1178809A1 (fr) 2002-02-13
CA2371231A1 (en) 2000-11-09
UY26131A1 (es) 2000-12-29
CN1359294A (zh) 2002-07-17
TR200103039T2 (tr) 2002-01-21
KR20020005735A (ko) 2002-01-17
NO20015295L (no) 2001-12-21
IS6084A (is) 2001-09-25
WO2000066130A1 (fr) 2000-11-09
HUP0202329A2 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
AR023789A1 (es) Composicion farmaceutica en forma unitaria que contiene acido acetilsalicilico y hidrogenosulfato de clopidogrel
ID27504A (id) Formulasi oral baru
ES2176684T3 (es) Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico.
IL152339A0 (en) Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
MX9604354A (es) Nueva forma de dosis farmaceutica oral.
BR0106912A (pt) Partìculas contendo ingrediente ativo
ES2037866T3 (es) Una composicion desodorante en forma de gel.
AR027450A1 (es) Formulacion nutricional con contenido de sustancias prebioticas
NO20011217D0 (no) Doseringsform omfattende væskeformulering
BRPI0412697A (pt) composições farmacêuticas que apresentam um revestimento expansìvel
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
ES2143481T3 (es) Comprimido de valproato de sodio de liberacion lenta.
DE69927374T2 (de) Entzündungshemmende pharmazeutische formulierungen
ATE313495T1 (de) Tablettenspender zur einzeldosierung von tabletten
CO4960657A1 (es) Composicion farmaceutica
AR020205A1 (es) Formulacion efervescente esterilizante.
AR030648A1 (es) Composicion farmaceutica con excipiente modificado
DE60110814D1 (de) Zusammensetzungen mit langsamer freigabe enthaltend lithium-carbonat
ATE258046T1 (de) Pharmazeutische, metamizol enthaltende brauseformulierung
IT1297233B1 (it) Composizioni farmaceutiche solide in forma di caramelle contenenti disinfettanti e sostanze mucoadesive per una disinfezione topica
BR0101880A (pt) Uma nova composição farmacêutica
WO2001091733A3 (de) Wirkstoffkombination enthaltend montirelin und eine verbindung mit opioider wirksamkeit
CO4370124A1 (es) Composicion efervescente para limpieza y desinfeccion ambiental
DE29805706U1 (de) Tablettenspender zur Einzeldosierung von Tabletten
BR9800942A (pt) Invólucro hidrossolúvel com esponja e similares de banho e com ou sem sabonete e. ou sais aromáticos e, ou outros de único uso.